Literature DB >> 1008063

Third component of complement in cystic fibrosis.

R J Holzhauer, J D Van Ess, R H Schwartz.   

Abstract

In a study of C3 levels and phenotypes in 64 cystic fibrosis (CF) patients, 92 CF parents, 64 normal siblings, and 126 healthy controls, significant elevations of mean C3 levels were found in CF patients, their parents, and in one genetic sub-group of their siblins (SS females). C3 concentration in CF patients correlated with the degree of clinical impairment as measured by Shwachman-Kulczycki (S-K) score. No significant differences were found in the prevalences of C3 phenotypes or the S and F gene frequencies among the groups studied.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008063      PMCID: PMC1685187     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Distribution of complement C3 variants in individuals with cystic fibrosis.

Authors:  S Lederberg; D Sackett
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

Review 3.  Cystic fibrosis: current concepts.

Authors:  M J Polley; A G Bearn
Journal:  J Med Genet       Date:  1974-09       Impact factor: 6.318

4.  Letter: Complement components in cystic fibrosis.

Authors:  S Hann; D S Holsclaw; H S Shin
Journal:  Lancet       Date:  1974-08-31       Impact factor: 79.321

5.  Letter: Complement components in cystic fibrosis.

Authors:  J H Conover; E J Conod; K Hirschhorn
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

6.  Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex.

Authors:  J H Conover; E J Conod; K Hirschhorn
Journal:  Life Sci       Date:  1974-01-16       Impact factor: 5.037

7.  High voltage agarose gel electrophoresis in the study of C 3 polymorphism.

Authors:  P Teisberg
Journal:  Vox Sang       Date:  1970-07       Impact factor: 2.144

8.  Letter: C3 in cystic fibrosis.

Authors:  T F Scanlin; M E Norman; M L Rosenlund
Journal:  Lancet       Date:  1975-06-21       Impact factor: 79.321

9.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

  9 in total
  2 in total

1.  Distribution of complement C3 variants in individuals with cystic fibrosis.

Authors:  S Lederberg; D Sackett
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

2.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.